JP2020527546A5 - - Google Patents

Download PDF

Info

Publication number
JP2020527546A5
JP2020527546A5 JP2019572724A JP2019572724A JP2020527546A5 JP 2020527546 A5 JP2020527546 A5 JP 2020527546A5 JP 2019572724 A JP2019572724 A JP 2019572724A JP 2019572724 A JP2019572724 A JP 2019572724A JP 2020527546 A5 JP2020527546 A5 JP 2020527546A5
Authority
JP
Japan
Prior art keywords
seq
peptide
amino acid
acid sequence
tlr7
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019572724A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020527546A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2018/050667 external-priority patent/WO2019000045A1/en
Publication of JP2020527546A publication Critical patent/JP2020527546A/ja
Publication of JP2020527546A5 publication Critical patent/JP2020527546A5/ja
Pending legal-status Critical Current

Links

JP2019572724A 2017-06-30 2018-06-29 治療方法 Pending JP2020527546A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2017902545 2017-06-30
AU2017902545A AU2017902545A0 (en) 2017-06-30 A method of treatment
PCT/AU2018/050667 WO2019000045A1 (en) 2017-06-30 2018-06-29 METHOD OF TREATMENT

Publications (2)

Publication Number Publication Date
JP2020527546A JP2020527546A (ja) 2020-09-10
JP2020527546A5 true JP2020527546A5 (enExample) 2021-07-29

Family

ID=64740713

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019572724A Pending JP2020527546A (ja) 2017-06-30 2018-06-29 治療方法

Country Status (6)

Country Link
US (2) US11319343B2 (enExample)
EP (1) EP3645030A4 (enExample)
JP (1) JP2020527546A (enExample)
CN (2) CN119548615A (enExample)
AU (1) AU2018293925B2 (enExample)
WO (1) WO2019000045A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119548615A (zh) * 2017-06-30 2025-03-04 皇家墨尔本理工大学 一种治疗方法
WO2022170396A1 (en) * 2021-02-12 2022-08-18 ViraLok Therapeutics Pty Ltd Agents and methods for therapy and prophylaxis
CN114532296B (zh) * 2021-12-14 2023-12-15 首都医科大学附属北京同仁医院 NOX2基因缺陷rd1小鼠模型及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ525914A (en) 1998-03-10 2004-03-26 Genentech Inc Novel polypeptides and nucleic acids encoding the same
ATE510850T1 (de) * 2000-09-15 2011-06-15 Coley Pharm Gmbh Verfahren zum hochdurchsatzscreening von auf cpg basierenden immunagonisten und -antagonisten
KR20110039381A (ko) * 2008-08-04 2011-04-15 이데라 파마슈티칼즈, 인코포레이티드 안티센스 올리고누클레오티드에 의한 톨-유사 수용체 7 발현의 조절
US8940310B2 (en) * 2010-06-16 2015-01-27 Dynavax Technologies Corporation Methods of treatment using TLR7 and/or TLR9 inhibitors
US20140378531A1 (en) * 2012-02-01 2014-12-25 New York University Inhibition of pattern recognition receptors in pancreatic cancer treatment using tlr inhibitors
US9228184B2 (en) * 2012-09-29 2016-01-05 Dynavax Technologies Corporation Human toll-like receptor inhibitors and methods of use thereof
WO2014174704A1 (ja) * 2013-04-22 2014-10-30 国立大学法人東京大学 炎症性疾患の予防又は治療剤
CN104211799B (zh) * 2013-05-29 2017-12-26 成都渊源生物科技有限公司 人源egf结构域蛋白及其应用
WO2015024669A1 (en) * 2013-08-21 2015-02-26 Curevac Gmbh Combination vaccine
US10308938B2 (en) * 2014-06-20 2019-06-04 Yale University Compositions and methods to activate or inhibit toll-like receptor signaling
CN119548615A (zh) * 2017-06-30 2025-03-04 皇家墨尔本理工大学 一种治疗方法

Similar Documents

Publication Publication Date Title
JP6995933B2 (ja) インターロイキン23受容体の経口ペプチド阻害剤および炎症性腸疾患を処置するためのそれらの使用
US8785375B2 (en) Cyclic antimicrobial peptides for treating bacterial infections
JP2014525901A5 (enExample)
JP2005519041A5 (enExample)
JP2014524908A5 (enExample)
HU217843B (hu) Paratiroid hormon (PTH) rokon polipeptidek, eljárások ezek előállítására és az ezeket tartalmazó gyógyszerek osteoporosis kezelésére
JP2020527546A5 (enExample)
HRP20140616T1 (hr) Peptidni analog oksintomodulina
JP2011524420A5 (enExample)
HRP20170890T1 (hr) Suagonisti glukagonskog/glp-1 receptora
JP5753077B2 (ja) 抗菌ペプチド多量体
HRP20210809T1 (hr) Biciklični peptidni ligandi specifični za mt1-mmp
KR20160063349A (ko) 알파나선형 세포 투과 펩타이드 다합체,이의 제조방법 및 그 용도
JP2016518351A5 (enExample)
RU2011134596A (ru) Аналоги оксинтомодулина
WO2017114240A1 (zh) 一种合成Etelcalcetide的方法
JP2012508698A5 (enExample)
US20160168203A1 (en) Cyclic Antimicrobial Peptides
JP2008522954A5 (enExample)
JP2017500316A5 (enExample)
JP2014519514A5 (enExample)
CN114644687A (zh) 一种可拮抗rbm25蛋白rna结合活性的多肽rbip-21及其应用
JP2015533372A5 (enExample)
KR20170073585A (ko) Cd44의 단리된 폴리펩타이드 및 이의 사용
KR20220139079A (ko) 세포 투과성 펩타이드 변이체 및 이의 용도